An Innovative Mental Health Virtual Ward: Evaluation of Patient-Centered Outcomes

July 31, 2025 updated by: University of Manitoba

The goal of this study is to evaluate if admission to the Mental Health Virtual Ward (MH vWard) for mental health crisis stabilization is having a meaningful positive impact on patient reported outcomes and healthcare utilization. The objectives of this study are:

  1. Prospectively measure demographic, recovery, service delivery, and systems use outcomes in a cohort of MH vWard admissions.
  2. establish this cohort for use in future research.

As part of the intervention, participants will receive care in the MH vWard for an average of 5 days following a visit to an emergency department or crisis centre for a mental health crisis. While admitted to the MH vWard, participants will:

  1. Engage in individual therapy and care planning with a clinician or psychiatry team.
  2. Have engagement with formal (community providers) and informal supports (family, friends) for collateral and collaboration.
  3. Receive medication reconciliation and management.
  4. Participate in group programming.
  5. Receive referrals for follow-up services.
  6. Have access to after hours support.
  7. Have access to the Telus Home Health Monitoring (HHM) App, which is custom designed to complement the services provided by the program.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3G 0N2
        • Crisis Stabilization Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Individuals admitted to the Mental Health Virtual Ward.

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mental Health Virtual Ward
Admission to the Mental Health Virtual Ward
Behavioral: Virtual crisis stabilization support with a multi-disciplinary team
Daily 1:1 sessions with multidisciplinary team via a range of virtual modalities (videoconferencing, phone, text, email), group programming, self-management resources, remote home monitoring app, referrals and linkages to community programs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The World Health Organization-Five (WHO-5) Well-Being Index
Time Frame: 1 week, 5 weeks and 6 months from date of discharge

The World Health Organization-Five (WHO-5) Well-Being Index is a questionnaire used for the assessment of subjective psychological well-being.

Five questions are answered on a scale of 1-5 (0 meaning the individual agrees with the statement "at no time", 5 meaning they agree with the statement "all of the time").

Minimum value: 0 Maximum value: 25 A higher score represents better quality of life and well-being, a lower score represents lower quality of life and well-being.
1 week, 5 weeks and 6 months from date of discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-discharge Healthcare Utilization (self-report)
Time Frame: 1 week post discharge, 5 weeks post discharge and 6 months from date of discharge

Number of participants who self-report further healthcare utilization following discharge from the virtual ward (all participants)

Systems use outcomes will include: emergency department visits, crisis centre visits, and psychiatric hospitalizations collected by self-report. Patients can answer questionnaires electronically, over the phone, or in person with a member of the research team.
1 week post discharge, 5 weeks post discharge and 6 months from date of discharge
Post-discharge Healthcare Utilization (administrative data)
Time Frame: 1 week post discharge, 5 weeks post discharge and 6 months from date of discharge

Number of participants with administrative data supporting further healthcare utilization following discharge from the virtual ward (urban participants only)

Systems use outcomes will include: emergency department visits, crisis centre visits, and psychiatric hospitalizations collected via healthcare administrative data. This data will be used to collect some systems use outcomes data on participants lost to follow-up in the study, as well as allow for the assessment of recall bias when compared to self-reporting of healthcare utilization.
1 week post discharge, 5 weeks post discharge and 6 months from date of discharge
Maryland Assessment of Recovery Scale-Twelve (MARS-12)
Time Frame: 1 week post discharge, 5 weeks post discharge, 6 months post-discharge

Maryland Assessment of Recovery Scale-Twelve (MARS-12) contains a list of statements about an individuals subjective attitude and beliefs towards their own health an wellness.

Twelve questions are answered on a scale from 1-5 (1 meaning the participant "not at all" agrees with the statement, 5 meaning the participant "very much" agrees with the statement).

Minimum value: 12 Maximum value: 60 A higher score represents a higher personal recovery post-discharge, a lower score represent a lower personal recovery post-discharge.
1 week post discharge, 5 weeks post discharge, 6 months post-discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Manitoba

Collaborators

Health Sciences Centre Foundation, Manitoba

Investigators

  • Principal Investigator: Jennifer Hensel, MD, University of Manitoba and Shared Health Manitoba/Psychiatry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2024

Primary Completion (Actual)

July 29, 2025

Study Completion (Actual)

July 29, 2025

Study Registration Dates

First Submitted

July 23, 2024

First Submitted That Met QC Criteria

July 23, 2024

First Posted (Actual)

July 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 6, 2025

Last Update Submitted That Met QC Criteria

July 31, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HS26297

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe